In the premiere episode of Mind, Body, & the Pause, Soma Mandal, MD, is joined by Manisha Parulekar, MD, and Jocelyn Carlo, MD, FACOG, to discuss the stages of the menopause transition.
|Articles|July 27, 2012
Case: Fistulas alleged to develop after hysterectomy
Author(s)Contemporary OB/GYN Staff
Was a hysterectomy the only viable option for this patient's irregular bleeding? Were the fistulas an outcome of hysterectomy? Read on for the facts of the case.
Advertisement
For details on the lawsuit, click "Next".
Advertisement
Related to this article
Mental health, bias, and trauma shape sexual health visits, and histories should assess function, not just risk, according to Sameena Rahman, MD.
This FAQ summarizes a Special Report discussion on off-label testosterone dosing, application, cost, and lab monitoring in women.
This FAQ summarizes a Special Report discussion on how two experts decide who is a candidate for testosterone therapy in women, from symptoms and context to hormone state vs age.
This FAQ summarizes a Special Report discussion of what the evidence does and does not establish about testosterone therapy in women.
Kanchi Chadha, MD, FACOG, MSCP, supports reconsidering MHT boxed warnings but says the FDA cited no study behind the change.
HRSA will award up to $1 million to a single organization to update the Women's Preventive Services Guidelines through the new WISH program.
Real-world data show maternal RSVpreF vaccination was 82% effective against infant RSV LRTI hospitalization through 3 months.
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
Centers for Medicare, Medicaid Services includes AMA's obstetric codes in 2027 fee schedule
2
FAQ: How is off-label testosterone dosed and monitored in women?
3
Q&A: Soma Mandal, MD, MSCP, on FDA boxed warning removals for MHT
4
Mental health, bias, and trauma: Building trust in sexual medicine
5